By expenditures
| Name | Title | Type |
|---|---|---|
| Cheryl McCarthy | Business Office Manager | Auditee |
| Mark Bertolozzi | Assistant Superintendent for Business Services | Auditee |
| Scott Duenser | Partner | Auditee |
| Chuck Gusswein | Assurance Manager | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 357207 | 2024 | 2025-05-27 | Wipfli LLP | $6.40M |
| 303545 | 2023 | 2024-04-15 | Wipfli LLP | $7.28M |
| 28651 | 2022 | 2023-04-10 | Wipfli LLP | $10.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 357207 | 2024 | 2025-05-27 | 1138020 | 2024-001 | - | Yes | ABEGLN |
| 357207 | 2024 | 2025-05-27 | 1138019 | 2024-001 | - | Yes | ABEGLN |
| 357207 | 2024 | 2025-05-27 | 1138018 | 2024-001 | - | Yes | ABEGLN |
| 357207 | 2024 | 2025-05-27 | 561578 | 2024-001 | - | Yes | ABEGLN |
| 357207 | 2024 | 2025-05-27 | 561577 | 2024-001 | - | Yes | ABEGLN |
| 357207 | 2024 | 2025-05-27 | 561576 | 2024-001 | - | Yes | ABEGLN |
| 303545 | 2023 | 2024-04-15 | 969708 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 969707 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 969706 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 969705 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 969704 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 969703 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 393266 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 393265 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 393264 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 393263 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 393262 | 2023-001 | Significant Deficiency | - | L |
| 303545 | 2023 | 2024-04-15 | 393261 | 2023-001 | Significant Deficiency | - | L |